They are formulated to support your body's natural GLP-1 production as part of a mindful health routine, not as a medical treatment
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
2 Treatment Unfortunately, the biggest concern with current therapy is that there are no efficacious treatments for slowing or halting disease progression
This approach delivers hydration, electrolytes, and essential vitamins directly into your bloodstream, often providing quick relief from symptoms
Domestic freezers and home storage are not appropriate for investigational medicinal products
By calming this chronic inflammation, GLP-1s can support better insulin sensitivity, hormone balance, and overall metabolic health
.png)
